Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-815
Closed -$267K 184
2025
Q4
$267K Sell
815
-22
-3% -$6.98K 0.14% 78
2025
Q3
$250K Sell
837
-219
-21% -$63.5K 0.07% 152
2025
Q2
$295K Buy
1,056
+70
+7% +$19.8K 0.09% 134
2025
Q1
$307K Sell
986
-37
-4% -$10.9K 0.1% 125
2024
Q4
$267K Sell
1,023
-117
-10% -$34.7K 0.08% 146
2024
Q3
$367K Sell
1,140
-196
-15% -$64.1K 0.1% 124
2024
Q2
$417K Sell
1,336
-2,182
-62% -$641K 0.12% 115
2024
Q1
$1M Sell
3,518
-4,089
-54% -$1.2M 0.15% 131
2023
Q4
$2.19M Sell
7,607
-117
-2% -$31.9K 0.17% 139
2023
Q3
$2.08M Sell
7,724
-2,266
-23% -$565K 0.17% 126
2023
Q2
$2.22M Buy
9,990
+6,102
+157% +$1.42M 0.12% 176
2023
Q1
$1.02M Hold
3,888
0.04% 288
2022
Q4
$1.02M Sell
3,888
-2,688
-41% -$721K 0.04% 288
2022
Q3
$1.48M Sell
6,576
-187
-3% -$45.3K 0.07% 225
2022
Q2
$1.65M Buy
6,763
+4,449
+192% +$1.09M 0.06% 234
2022
Q1
$560K Sell
2,314
-4,645
-67% -$1.07M 0.02% 477
2021
Q4
$1.57M Sell
6,959
-15,769
-69% -$3.33M 0.04% 270
2021
Q3
$4.83M Buy
22,728
+1,713
+8% +$394K 0.15% 116
2021
Q2
$5.12M Buy
21,015
+2,442
+13% +$601K 0.17% 109
2021
Q1
$4.62M Sell
18,573
-2,326
-11% -$555K 0.17% 110
2020
Q4
$4.8M Buy
20,899
+1,130
+6% +$261K 0.2% 104
2020
Q3
$5.02M Sell
19,769
-579
-3% -$143K 0.24% 95
2020
Q2
$4.8M Sell
20,348
-1,592
-7% -$363K 0.25% 91
2020
Q1
$4.45M Buy
21,940
+2,181
+11% +$476K 0.29% 84
2019
Q4
$4.76M Buy
19,759
+3,420
+21% +$754K 0.26% 88
2019
Q3
$3.16M Sell
16,339
-13,384
-45% -$2.57M 0.22% 96
2019
Q2
$5.48M Buy
29,723
+127
+0.4% +$22.7K 0.21% 97
2019
Q1
$5.62M Buy
29,596
+3,396
+13% +$649K 0.23% 86
2018
Q4
$5.1M Sell
26,200
-19,911
-43% -$3.88M 0.42% 42
2018
Q3
$9.56M Sell
46,111
-581
-1% -$115K 0.36% 58
2018
Q2
$8.62M Buy
46,692
+3,781
+9% +$669K 0.31% 66
2018
Q1
$7.32M Sell
42,911
-10,031
-19% -$1.84M 0.22% 85
2017
Q4
$9.21M Buy
52,942
+616
+1% +$109K 0.25% 73
2017
Q3
$9.76M Buy
52,326
+1,443
+3% +$256K 0.27% 72
2017
Q2
$8.76M Sell
50,883
-7,423
-13% -$1.21M 0.26% 68
2017
Q1
$9.57M Buy
58,306
+16,249
+39% +$2.7M 0.29% 65
2016
Q4
$6.15M Buy
42,057
+20,961
+99% +$3.15M 0.18% 113
2016
Q3
$3.52M Buy
21,096
+3,664
+21% +$620K 0.15% 118
2016
Q2
$2.65M Buy
17,432
+887
+5% +$138K 0.12% 145
2016
Q1
$2.48M Buy
16,545
+7,016
+74% +$1.04M 0.11% 160
2015
Q4
$1.55M Buy
9,529
+2,061
+28% +$324K 0.07% 245
2015
Q3
$1.03M Sell
7,468
-5,473
-42% -$863K 0.09% 235
2015
Q2
$1.83M Buy
12,941
+4,041
+45% +$647K 0.09% 199
2015
Q1
$1.42M Sell
8,900
-4,501
-34% -$709K 0.03% 458
2014
Q4
$2.13M Buy
13,401
+2,952
+28% +$460K 0.13% 137
2014
Q3
$1.47M Sell
10,449
-1,715
-14% -$224K 0.1% 214
2014
Q2
$1.44M Buy
12,164
+2,622
+27% +$304K 0.09% 235
2014
Q1
$1.18M Buy
9,542
+6,429
+207% +$780K 0.1% 207
2013
Q4
$372K Buy
3,113
+305
+11% +$34.7K 0.04% 448
2013
Q3
$314K Sell
2,808
-779
-22% -$84.5K 0.04% 418
2013
Q2
$354K Buy
+3,587
New +$372K 0.05% 336

Other funds holding AMGN

FDx Advisors's AMGN Position: Q1 2026 in Review

FDx Advisors sold out of Amgen (AMGN) in Q1 2026, closing a stake of 815 shares — an estimated $267K sold.

FDx Advisors first reported a position in AMGN in Q2 2013 and held it in 51 quarters. The position peaked at $9.76M in Q3 2017. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • FDx Advisors reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • FDx Advisors sold 815 Amgen shares in Q1 2026, an estimated $267K.
  • FDx Advisors first reported a position in Amgen in Q2 2013 and held it in 51 quarters.
  • FDx Advisors's Amgen position peaked at $9.76M in Q3 2017.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on FDx Advisors's 13F filing for Q1 2026, filed 1 May 2026.